ASP1517 Pharmacokinetics Study in Anemia Patients on Hemodialysis
Status:
Completed
Trial end date:
2010-06-07
Target enrollment:
Participant gender:
Summary
To assess the Pharmacokinetics and pharmacodynamics of single doses of ASP1517 in renal
anemia patients on hemodialysis. Safety and tolerability will be also evaluated in these
patients.